Latest Solta Medical Inc. Stories
HAYWARD, Calif., March 1 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced the successful completion of its acquisition of Aesthera Corporation. The transaction brings together the Isolaz(TM) brand of products for the treatment of acne with Solta's leading brands for skin tightening and skin resurfacing, Thermage(TM) and Fraxel(TM). "We are delighted with the swift completion of the acquisition of Aesthera which...
HAYWARD, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Clint Carnell, Chief Operating Officer, will participate in Lazard Capital Markets' 2nd Annual Medical Technology Conference this Thursday, February 25, 2010 at the Cliff Lodge in Snowbird, Utah. The conference format consists of a full day of one-on-one meetings. The conference will not be webcast. About Solta Medical, Inc. Solta...
HAYWARD, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced results for the fourth quarter and full year ended December 31, 2009. Revenue for the fourth quarter was in-line with the preliminary forecast provided on January 8, 2010. Revenue for the fourth quarter was $28.4 million, an increase of approximately $18.9 million, or 197%, as compared to the fourth quarter 2008 revenue of $9.5 million...
HAYWARD, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of...
HAYWARD, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that it will release its financial results for the fourth quarter ended December 31, 2009, before market open on Tuesday, February 23, 2010. The Company will also host a conference call and webcast on Tuesday, February 23, 2010, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific) to discuss the financial results and current corporate...
NEWPORT COAST, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM) today announced the donation of a Fraxel re:store laser system to the Grossman Burn Foundation, the philanthropic arm of the Grossman Burn Center, a worldwide leader in innovative treatment and care for burn patients and their families. The Fraxel re:store system will be used to reduce the appearance of scarring caused by traumatic thermal damage. "Solta Medical is pleased to donate a Fraxel re:store...
HAYWARD, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 12th Annual Needham Growth Stock Conference at the New York Palace Hotel. The Company's presentation is scheduled for 9:20 a.m. Eastern Time on January 14, 2010. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events. Solta...
HAYWARD, Calif., Jan. 8 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM) today announced that it has obtained commitments from accredited institutional investors to purchase approximately $17.2 million of its common stock and warrants in a private placement. The financing was led by existing investor Longitude Capital and new investor Great Point Partners along with participation from other existing investors. Solta has entered into a securities purchase agreement with the investors...
HAYWARD, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and market leader of aesthetic skin treatments, today announced its European launch of the Fraxel re:store Dual laser system with the recent CE Mark (Conformite Europeene) approval. The Fraxel re:store Dual system takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser...
HAYWARD, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced results for the third quarter ended September 30, 2009. Revenue for the quarter was in-line with the preliminary forecast provided on September 28th. Revenue for the third quarter was $17.8 million, an increase of approximately $4.7 million, or 36%, as compared to the third quarter 2008 reflecting increased revenue as a result of the...
